Table 2: Hemoglobin before sample collection and hematological parameters of study participants by duration of stay prior to transfusion (Mean ± SEM).

Characteristic

N

Hb

(g/dl)

WBC

(109/L)

LYMT

(109/L)

MID

(109/L)

GRAN

(109/L)

RBC

(1012/)

Hb

(g/dL)

HCT

(%)

MCV (fL)

MCH (pg)

Duration

(Baseline)

52

 

13.84 ± 0.147

 

4.08 ± 0.278a

 

2.68 ± 0.179a

 

0.41 ± 0.064ab

 

0.96 ± 0.068a

 

2.39 ± 0.154

 

7.54 ± 0.523

 

22.79 ± 1.570a

 

84.61 ± 0.667a

 

28.87 ± 0.325abc

 

7

 

52

 

13.84 ± 0.147

 

3.00 ± 0.339b

 

2.43 ± 0.284ab

 

0.27 ± 0.034bc

 

0.31 ± 0.068b

 

2.89 ± 0.210

 

7.92 ± 0.558

 

24.18 ± 1.725a

 

84.99 ± 0.742a

 

28.26 ± 0.291c

 

14

 

52

 

13.84 ± 0.147

 

1.83 ± 0.104c

 

1.74 ± 0.219bc

 

0.46 ± 0.076a

 

0.16 ± 0.068b

 

2.75 ± 0.171

 

7.62 ± 0.530

 

23.11 ± 1.603a

 

80.18 ± 0.756b

 

28.76 ± 0.285bc

 

21

 

52

 

13.84 ± 0.147

 

0.83 ± 0.053d

 

1.27 ± 0.111cd

 

0.21 ± 0.037c

 

0.20 ± 0.068b

 

2.50 ± 0.180

 

7.46 ± 0.549

 

24.71 ± 1.822a

 

75.63 ± 0.669c

 

29.70 ± 0.339 ab

 

28

 

52

 

13.84 ± 0.147

 

0.83 ± 0.053d

 

097 ± 0.041d

 

0.09 ± 0.004c

 

0.06 ± 0.068b

 

2.38 ± 0.168

 

7.28 ± 0.532

 

26.77 ± 1.397b

 

77.53 ± 0.669bc

 

30.07 ± 0.316 a

 

35

52

 

13.84 ± 0.147

0.92 ± 0.062d

0.74 ± 0.054d

0.10 ± 0.000c

0.06 ± 0.068b

2.42 ± 0.169

7.03 ± 0.495

23.46 ± 1.689a

75.29 ± 0.669c

29.44 ± 0.314abc

F-Ratio

 

0.000

52.148

20.905

11.619

25.336

1.486

0.3223

3.103

38.406

4.609

P-value

 

1.000

< 0.0001****

< 0.0001****

< 0.0001****

< 0.0001****

0.1941

0.8994

0.0095**

< 0.0001****

0.0005***

Significance Level: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001